2024澳科资料1688-资料免费精选
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2021.03.30
关于续聘会计师事务所的公告
2021.03.30
关于开展2021年度外汇衍生品交易的公告
2021.03.30
关于使用部分H股闲置募集资金购买理财产品及进行现金管理的公告
2021.03.30
关于2021年度向银行申请授信额度暨提供担保的公告
2021.03.30
年度募集资金使用情况专项说明
2021.03.30
内部控制鉴证报告
2021.03.30
内部控制自我评价报告
2021.03.30
关于开展外汇衍生品交易的可行性分析报告
2021.03.30
未来三年（2021年-2023年）股东回报规划
2021.03.30
内部控制规则落实自查表
第一页
上一页
22
23
24
25
26
下一页
最后一页
